Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2011/091/000041
CTRI/2011/091/000041
Completed
Phase 4

Assessment of Efficacy, Safety and Tolerability of D?acne (Clindamycin Phosphate 1% and zinc acetate) in the treatment of Acne.

Glenmark Pharmaceuticals Ltd0 sites125 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Glenmark Pharmaceuticals Ltd
Enrollment
125
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • •?Subjects with mild to moderate inflammatory acne with comedones, papules or pustules predominate (Grade 1 and grade 2, IADVL acne grading system) affecting face
  • •?Subjects must be 18\-40 years of age
  • •?Subjects must provide written informed consent and comply to the protocol

Exclusion Criteria

  • •?Subjects not willing to discontinue all topical treatments for Acne for 2 weeks prior to enrollment in study
  • •?Hypersensitivity to any ingredients of D?acne
  • •?Pregnant and lactating women.
  • •?Subjects taking Concomitant therapy that might interfere with the study results in the investigator?s opinion.
  • •?Subjects with dermatological disorder of face that may interfere with study evaluation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Assessment of Efficacy, Safety and Tolerability of Fixed Dose Combination Wunder Eye Cream (3% Biophytex LS 8740 an 5% Proteasyl TP LS 8657) in the treatment of under Eye Dark Circles.
CTRI/2011/04/001672Glenmark Pharmaceuticals Limited20
Completed
Phase 4
A clinical trial to study the effect of Hair4U 10% containing (minoxidil 10% plus Aminexil 1.5%)in treatment of male pattern of baldnessHealth Condition 1: null- Androgenetic Alopecia
CTRI/2011/06/001813Glenmark Pharmaceuticals Ltd75
Completed
Not Applicable
Observational Study on cough syrupHealth Condition 1: null- productive cough (cough with expectoration) associated with any of the nasal symptoms (nasal discharge,nasal stuffiness, nasal itching, and Sneezing) since at least previous 8 hours
CTRI/2015/09/006198Dr Reddys laboratories Ltd250
Completed
Phase 4
Study of Efficacy, Safety and Tolerability of Na-Picosulphate in patients requiring anorectal surgeryHealth Condition 1: null- Patients requiring bowel preparation for gastrointestinal or anorectal surgery
CTRI/2016/09/007292VYAS SURGERY100
Recruiting
Phase 4
Assessment of Steroneo Skin Cream (Physalis Angulata Supercritical Extract) application for treatment of eczematous lesions
CTRI/2016/11/007511Rehmat Clinic50